Cytolytic activity score (CYT), defined as the sum of expression of granzyme A (GZMA) and perforin (PRF1), was used to evaluate overall anti-cancer immune cell killing in the tumor microenvironment (25594174). The gene discussed is PRF1; the disease is neoplasm.